Invivyd Inc
Change company Symbol lookup
Select an option...
IVVD Invivyd Inc
DARE Dare Bioscience Inc
REXR-C Rexford Industrial Realty Inc
AQNA Algonquin Power & Utilities Corp
NAOV Nanovibronix Inc
IOT Samsara Inc
GSIT GSI Technology Inc
GME GameStop Corp
CMBM Cambium Networks Corp
S SentinelOne Inc
Go

Health Care : Biotechnology |
Company profile

Invivyd, Inc. is a biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases. It delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2 (COVID-19). Its technology works at the intersection of evolutionary virology, predictive modeling, and antibody engineering, and is designed to identify antibodies with a barrier to viral escape. It has a robust pipeline of antibody candidates for the prevention and treatment of COVID-19, including VYD222, a novel antibody. VYD222 is a monoclonal antibody candidate that has demonstrated in vitro neutralizing activity against dominant variants of concern, including XBB.1.5. VYD222 was engineered from adintrevimab (ADG20), which provided neutralizing protection against SARS-CoV-2 for all variants of concern until the emergence of the Omicron BA.2 strain and its sublineages.

Postmarket

Last Trade
Delayed
$1.49
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.49
Day's Change
-0.015 (-1.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.57
Day's Low
1.48
Volume
(Light)
Volume:
169,199

10-day average volume:
305,977
169,199
  • Prev Close
    1.50
  • Today's Open
    1.56
  • Day's Range
    1.48-1.57
  • Avg Vol (10-day)
    306.0K
  • Last (time)
    4:00p ET 06/02/23
  • Last (size)
    53
  • 52-Wk Range
    1.03 - 4.90
    LowHigh
  • (08/22/22 - 04/26/23)
    44.17%
  • 93.3%
  • Market Cap
    162.6M
  • Shares Outstanding
    109.5M
  • -1.62
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 72.97
  • (% of float 05/15/23)
    3.75

Latest News

June 01, 2023
7:00 am ET
Globe Newswire
May 26, 2023
9:00 pm ET
BusinessWire
May 11, 2023
4:01 pm ET
Globe Newswire
May 04, 2023
4:01 pm ET
Globe Newswire
April 25, 2023
4:01 pm ET
Globe Newswire
7:00 am ET
Globe Newswire
April 12, 2023
7:00 am ET
Globe Newswire
April 03, 2023
11:00 am ET
Globe Newswire
11:00 am ET
BusinessWire
10:12 am ET
Accesswire
9:08 am ET
Newsfile
7:41 am ET
Newsfile
6:05 am ET
PR Newswire
5:45 am ET
PR Newswire
April 02, 2023
8:44 pm ET
Accesswire
8:37 am ET
Newsfile
April 01, 2023
9:44 pm ET
Accesswire
6:46 pm ET
Newsfile
March 31, 2023
9:00 pm ET
BusinessWire
8:00 pm ET
BusinessWire
3:29 pm ET
Accesswire
12:00 pm ET
BusinessWire
11:00 am ET
Accesswire
10:30 am ET
PR Newswire
8:03 am ET
Newsfile
5:45 am ET
PR Newswire
March 30, 2023
11:16 pm ET
Accesswire
4:55 pm ET
Globe Newswire
4:32 pm ET
Accesswire
4:01 pm ET
Globe Newswire
3:47 pm ET
Newsfile
12:47 pm ET
Newsfile
12:46 pm ET
Globe Newswire
12:01 pm ET
Globe Newswire
11:01 am ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.